These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12876510)

  • 1. [Towards an improved antenatal screening for cystic fibrosis].
    Serre JL; Feingold J; Simon-Bouy B; Muller F
    Rev Epidemiol Sante Publique; 2003 Apr; 51(2):245-53. PubMed ID: 12876510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the risk of cystic fibrosis with abnormal ultrasound signs of fetal bowel: results of a French molecular collaborative study based on 641 prospective cases.
    Muller F; Simon-Bouy B; Girodon E; Monnier N; Malinge MC; Serre JL;
    Am J Med Genet; 2002 Jun; 110(2):109-15. PubMed ID: 12116247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focus on cystic fibrosis and other disorders evidenced in fetuses with sonographic finding of echogenic bowel: 16-year report from Brittany, France.
    Scotet V; Duguépéroux I; Audrézet MP; Audebert-Bellanger S; Muller M; Blayau M; Férec C
    Am J Obstet Gynecol; 2010 Dec; 203(6):592.e1-6. PubMed ID: 20932506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperechogenic fetal bowel as a marker of fetal cystic fibrosis].
    Sukupová M; Dhaifalah I; Adamík Z; Havalová J
    Ceska Gynekol; 2015 Jan; 80(1):20-4. PubMed ID: 25723074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conditions and limitations of healthy carrier screening for the mutation responsible for cystic fibrosis].
    Serre JL; Feingold J
    Rev Epidemiol Sante Publique; 1993; 41(5):353-62. PubMed ID: 8284475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis screening: a fetus with hyperechogenic bowel may be the index case.
    Muller F; Dommergues M; Simon-Bouy B; Ferec C; Oury JF; Aubry MC; Bessis R; Vuillard E; Denamur E; Bienvenu T; Serre JL
    J Med Genet; 1998 Aug; 35(8):657-60. PubMed ID: 9719372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier screening for cystic fibrosis.
    Dungan JS
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of public health strategies on the birth prevalence of cystic fibrosis in Brittany, France.
    Scotet V; Audrézet MP; Roussey M; Rault G; Blayau M; De Braekeleer M; Férec C
    Hum Genet; 2003 Aug; 113(3):280-5. PubMed ID: 12768409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between carrier screening and incidence of cystic fibrosis.
    Castellani C; Picci L; Tamanini A; Girardi P; Rizzotti P; Assael BM
    JAMA; 2009 Dec; 302(23):2573-9. PubMed ID: 20009057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Carrier Frequency of CFTR Gene Mutations in Pregnancies With Echogenic Bowel in Nova Scotia and Prince Edward Island.
    Miller ME; Allen VM; Brock JK
    J Obstet Gynaecol Can; 2018 Jul; 40(7):896-902. PubMed ID: 29503250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the risk of cystic fibrosis with echogenic fetal bowel and one cystic fibrosis mutation.
    Bosco AF; Norton ME; Lieberman E
    Obstet Gynecol; 1999 Dec; 94(6):1020-3. PubMed ID: 10576193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of fetal echogenic bowel.
    Al-Kouatly HB; Chasen ST; Streltzoff J; Chervenak FA
    Am J Obstet Gynecol; 2001 Nov; 185(5):1035-8. PubMed ID: 11717628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal detection of cystic fibrosis by ultrasonography: a retrospective study of more than 346 000 pregnancies.
    Scotet V; De Braekeleer M; Audrézet MP; Quéré I; Mercier B; Duguépéroux I; Andrieux J; Blayau M; Férec C
    J Med Genet; 2002 Jun; 39(6):443-8. PubMed ID: 12070257
    [No Abstract]   [Full Text] [Related]  

  • 14. Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation.
    Ogino S; Wilson RB; Grody WW
    J Med Genet; 2004 May; 41(5):e70. PubMed ID: 15121798
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperechogenic fetal bowel: a large French collaborative study of 682 cases.
    Simon-Bouy B; Satre V; Ferec C; Malinge MC; Girodon E; Denamur E; Leporrier N; Lewin P; Forestier F; Muller F;
    Am J Med Genet A; 2003 Sep; 121A(3):209-13. PubMed ID: 12923859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-trimester hyperechogenic bowel in a fetus of Japanese origin carrying a new mutation of CFTR gene (L548Q).
    Yamamoto M; Molina-Gomes D; Girodon-Boulandet E; Moulis M; Leroy B; Simon-Bouy B; Selva J; Ville Y
    Prenat Diagn; 2006 Jan; 26(1):6-8. PubMed ID: 16378323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperechogenic fetal bowel: counseling difficulties.
    Marcus-Soekarman D; Offermans J; Van den Ouweland AM; Mulder AL; Muntjewerff N; Vossen M; Kleijer W; Schrander-Stumpel C; Dooijes D
    Eur J Med Genet; 2005; 48(4):421-5. PubMed ID: 16378926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of cystic fibrosis mutations in pregnancies with fetal echogenic bowel.
    Sepulveda W; Leung KY; Robertson ME; Kay E; Mayall ES; Fisk NM
    Obstet Gynecol; 1996 Jan; 87(1):103-6. PubMed ID: 8532242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
    J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of CFTR mutation screening in cases of isolated fetal echogenic bowel in the South Australian population.
    Nicholls CM; Nelson PV; Poplawski NK; Chin SJ; Fong BA; Solly PB; Fietz MJ; Fletcher JM
    Prenat Diagn; 2003 Dec; 23(12):1023-5. PubMed ID: 14663844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.